Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II

European Journal of Pharmacology
Yong-Zhong HouYing-Jin Yuan

Abstract

The aim of this study was to determine the effects of ferulic acid on the proliferation and molecular mechanism in cultured vascular smooth muscle cell (VSMC) induced by angiotensin II. It was shown that ferulic acid significantly inhibited angiotensin II-induced VSMC proliferation in a dose-dependent manner. Western blotting analyses suggest that the antiproliferative effect of ferulic acid was involved in the mitogen-activated protein kinases (MAPKs) pathway. While no effect on p38, ferulic acid markedly inactivated the extracellular signal-regulated kinases (ERK1/2) and c-Jun N-terminal kinases (JNK), indicating that the inhibition of ferulic acid on VSMC proliferation was associated with ERK1/2 and JNK rather than p38 pathway. On the expression of cell cycle regulatory proteins, ferulic acid elevated the protein content of p21(waf1/cip1), decreased expression of cyclin D1 and inhibited phosphorylation of retinoblastoma protein, suggesting that ferulic acid inhibited VSMC proliferation by regulating the cell progression from G1 to S phase. The inactivation of MAPKs and modulation of cell cycle proteins of ferulic acid may be of importance in preventing cardiovascular disease.

References

Oct 1, 1992·Canadian Journal of Physiology and Pharmacology·E K ChiuJ R McNeill
Feb 20, 1986·The New England Journal of Medicine·R Ross
Nov 18, 1994·Cell·C J Sherr
May 12, 1994·Nature·J M KyriakisJ R Woodgett
Jan 1, 1996·The Journal of Clinical Investigation·J C TsaiM E Lee
Aug 23, 1996·The Journal of Biological Chemistry·J N LavoieJ Pouysségur
Sep 13, 1996·The Journal of Biological Chemistry·G WatanabeR G Pestell
Mar 5, 1998·Circulation Research·F C TannerE G Nabel
Apr 30, 1998·Current Opinion in Cell Biology·Y T Ip, R J Davis
Feb 1, 2002·Neurochemistry International·Shinichi TakahashiYasuo Fukuuchi
Sep 26, 2002·Journal of the American Chemical Society·Benoît BraïdaPhilippe C Hiberty
May 24, 2003·Biochemical and Biophysical Research Communications·Ulrich KintscherRonald E Law
Apr 27, 2004·Experimental Eye Research·James D ZieskeXiaoqing Guo
Sep 6, 2005·Biological & Pharmaceutical Bulletin·Wen Chao ZhaoHsiao Chang Chan
Mar 31, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Shuang LiuLiegang Liu
Oct 20, 2009·Journal of Cardiovascular Pharmacology and Therapeutics·Dongxian ZhangYongyi Bi
Jul 27, 2010·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Shuang LiRonghua Zhu

❮ Previous
Next ❯

Citations

Oct 16, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Venkata Reddy Bandugula, Rajendra Prasad N
Dec 22, 2005·Infection and Immunity·Ghada S HassanHerbert B Tanowitz
Mar 2, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Helmut M HügelCharlie C Xue
Jun 13, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bumjung KimHo-Young Choi
May 9, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Erlin Zhang, Feng Shen
Mar 8, 2016·European Journal of Pharmacology·Qian HongYue Gao
Apr 23, 2013·Luminescence : the Journal of Biological and Chemical Luminescence·Li ShuaiTianming Yang
Jan 30, 2015·Journal of Biomedical Materials Research. Part a·Erlin Zhang, Feng Shen
Feb 14, 2015·In Vitro Cellular & Developmental Biology. Animal·Yuan-Yuan BianHui-Ming Zhou
May 20, 2015·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Kanagalakshmi AmbothiAgilan Balupillai
Jul 4, 2016·Inflammopharmacology·Manoj Aswar, Vijay Patil
Sep 1, 2015·Experimental & Molecular Medicine·Yung-Chieh TsaiPao-Yun Cheng
Sep 8, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weixia LiJin-Ao Duan
Feb 23, 2007·Journal of Separation Science·Wen-Ying Huang, Shuenn-Jyi Sheu
Jan 30, 2020·Biomaterials Science·Angela Varela-GarciaCarmen Alvarez-Lorenzo
Nov 29, 2012·Journal of Cardiovascular Pharmacology·Md Ashraful AlamLindsay Brown
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Guangdong YangRui Wang
Feb 9, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Urmila AswarManoj Aswar
Aug 28, 2020·International Journal of Molecular Sciences·Fatin Farhana JubaidiSiti Balkis Budin
Aug 11, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Huiqin ZhangHao Li
Jul 16, 2009·Journal of Agricultural and Food Chemistry·Zhaohui ZhaoMohammed H Moghadasian
May 21, 2021·Journal of Traditional and Complementary Medicine·Frederick AyerteyLaud Kenneth Okine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.